X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs BIOCON LTD - Comparison Results

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB BIOCON LTD UNICHEM LAB/
BIOCON LTD
 
P/E (TTM) x 29.9 82.9 36.1% View Chart
P/BV x 3.1 7.8 40.3% View Chart
Dividend Yield % 0.6 0.2 379.6%  

Financials

 UNICHEM LAB   BIOCON LTD
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
BIOCON LTD
Mar-17
UNICHEM LAB/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs3341,162 28.7%   
Low Rs174483 36.1%   
Sales per share (Unadj.) Rs146.9194.6 75.5%  
Earnings per share (Unadj.) Rs11.934.4 34.6%  
Cash flow per share (Unadj.) Rs16.248.3 33.5%  
Dividends per share (Unadj.) Rs2.001.00 200.0%  
Dividend yield (eoy) %0.80.1 647.4%  
Book value per share (Unadj.) Rs105.1241.9 43.5%  
Shares outstanding (eoy) m90.84200.00 45.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.74.2 40.9%   
Avg P/E ratio x21.423.9 89.4%  
P/CF ratio (eoy) x15.717.0 92.1%  
Price / Book Value ratio x2.43.4 71.1%  
Dividend payout %16.82.9 578.6%   
Avg Mkt Cap Rs m23,073164,440 14.0%   
No. of employees `0005.79.2 61.4%   
Total wages/salary Rs m2,5587,470 34.2%   
Avg. sales/employee Rs Th2,352.54,213.9 55.8%   
Avg. wages/employee Rs Th450.9809.0 55.7%   
Avg. net profit/employee Rs Th190.4745.2 25.6%   
INCOME DATA
Net Sales Rs m13,34638,911 34.3%  
Other income Rs m1921,571 12.2%   
Total revenues Rs m13,53840,482 33.4%   
Gross profit Rs m1,6399,795 16.7%  
Depreciation Rs m3902,772 14.1%   
Interest Rs m29260 11.1%   
Profit before tax Rs m1,4128,334 16.9%   
Minority Interest Rs m0163 0.0%   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m2931,616 18.1%   
Profit after tax Rs m1,0806,881 15.7%  
Gross profit margin %12.325.2 48.8%  
Effective tax rate %20.719.4 106.9%   
Net profit margin %8.117.7 45.8%  
BALANCE SHEET DATA
Current assets Rs m5,97940,477 14.8%   
Current liabilities Rs m2,43216,783 14.5%   
Net working cap to sales %26.660.9 43.7%  
Current ratio x2.52.4 101.9%  
Inventory Days Days6360 105.8%  
Debtors Days Days6083 72.9%  
Net fixed assets Rs m6,40345,073 14.2%   
Share capital Rs m1821,000 18.2%   
"Free" reserves Rs m9,29347,377 19.6%   
Net worth Rs m9,54848,377 19.7%   
Long term debt Rs m23021,082 1.1%   
Total assets Rs m12,84393,942 13.7%  
Interest coverage x50.033.1 151.4%   
Debt to equity ratio x00.4 5.5%  
Sales to assets ratio x1.00.4 250.9%   
Return on assets %8.67.6 113.6%  
Return on equity %11.314.2 79.6%  
Return on capital %14.312.6 113.7%  
Exports to sales %29.20-   
Imports to sales %6.30-   
Exports (fob) Rs m3,900NA-   
Imports (cif) Rs m847NA-   
Fx inflow Rs m4,35612,988 33.5%   
Fx outflow Rs m1,1627,899 14.7%   
Net fx Rs m3,1945,089 62.8%   
CASH FLOW
From Operations Rs m1,1196,400 17.5%  
From Investments Rs m-853-4,985 17.1%  
From Financial Activity Rs m-334-1,775 18.8%  
Net Cashflow Rs m-68-473 14.4%  

Share Holding

Indian Promoters % 50.1 40.4 124.0%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 15.1 8.4 179.8%  
FIIs % 3.0 10.7 28.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 19.9 159.3%  
Shareholders   20,176 109,995 18.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  DISHMAN PHARMA  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Firm US Markets; Sun Pharma, Software Stocks & Other Top Cues to Sway the Markets Today(Pre-Open)

Indian share markets finished the previous trading session on a strong note amid firm Asian markets after comments from a Federal Reserve official eased worries about faster rate hikes in US.

Related Views on News

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

A New Quest for the Stock Market's MOST Profitable Ideas...(Smart Contrarian)

Feb 23, 2018

If you want to receive the best ideas in the Indian stick markets...you need to heed this important announcement.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Feb 23, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS